Lynparza is the first medicine targeting BRCA mutations to show clinical benefit in adjuvant setting
Month: June 2021
Virtual event from OVID and the Patient Partnership Index is now open for registration
Officials warned that early evidence suggests there may be an increased risk of hospitalisation for Delta compared to […]
Who decides when covid-19 restrictions are lifted? A government might lay out plans for reopening society. It might […]
Roche’s oral SMA med Evrysdi turned down by U.K. cost watchdog—despite prior nods for Zolgensma and Spinraza nhigginsdunn […]
J&J touts Tremfya win in Humira-resistant psoriatic arthritis patients amid showdown with AbbVie’s Skyrizi aliu Thu, 06/03/2021 – […]
With expansion, UK dermatology CDMO MedPharm will double its presence in the US kdunleavy Thu, 06/03/2021 – 10:19
AstraZeneca in talks to produce COVID-19 vaccine for feds at Catalent site in Maryland: report fkansteiner Thu, 06/03/2021 […]
Valneva’s not too late in COVID-19 as analysts eye $1.1B in 2022 vaccine sales nhigginsdunn Thu, 06/03/2021 – […]
Researchers from Aarhus University have developed electronic support stockings and tested them on bed-ridden Covid patients at Copenhagen […]